Pharma & Biotech

Celularity Inc. shares continued their downward trajectory on Friday, declining 3.76 percent to close at $2.05. During the trading session,...

German biotechnology firm BioNTech faces mounting investor anxiety as its stock experiences a significant downturn. Despite reporting extraordinary revenue growth,...

The biotechnology sector is currently experiencing unprecedented merger and acquisition activity, with Viking Therapeutics emerging as a potential target in...

Dare Bioscience shares experienced significant price swings following the biotechnology firm's announcement of a $4 million non-dilutive grant for its...

ZimVie Inc. is poised to conclude its tenure as a publicly traded entity after shareholders formally approved its acquisition by...

Akari Therapeutics experienced significant price volatility following the company's latest move to strengthen its intellectual property portfolio. The biopharmaceutical firm...

NRX Pharmaceuticals experienced a dramatic sell-off on Friday, with its stock price collapsing by nearly 11% to close at $3.17....

While Ocuphire Pharma's stock celebrates a spectacular rally, reaching new annual peaks with a stunning 50% surge over the past...

Rockwell Medical's stock continues its relentless downward trajectory, with Friday's trading session delivering another devastating blow to shareholder value. The...

FibroGen's stock continued its downward trajectory on Friday, closing at $10.55 after declining 3.74% during the trading session. This latest...